Life Sciences

Hologic, a Marlborough based medical technology company specializing in women's health, reported a net income of $268.4 million for the company’s third quarter in an earnings report released on Wednesday.

Massachusetts employers, especially those in skilled trades, often talk about the need to continuously attract, train and retain workers with in-demand skills, and though they are developing COVID-19 vaccines here, Moderna and Pfizer are not immune to the problem.

Boston Scientific reported $172 million in profits during the company’s second quarter, continuing a positive financial trend following a $328-million profit reported in the company’s first quarter.

Cytiva and Pall Corp. announced on Tuesday a plan to invest $1.5 billion dollars over two years to meet what the companies called growing demand for biotechnology solutions.

MBI President and CEO Jon Weaver spoke with WBJ about the company’s history, its current growth, and new programming.

Albany company Curia, a contract research, development and manufacturing company formerly known as AMRI, announced it has entered into an agreement to acquire LakePharma Inc.

The Cryo-EM Core facility at UMass Medical School received $2.8 million from the Massachusetts Life Sciences Center on Thursday to purchase a cryo-electron microscope to support the team’s structural biology research. 

Natick healthcare firm Allurion Technologies has rebranded its products to integrate its weight-loss balloon that doesn't require surgery and passes naturally through the body with a weight-loss program with a digital app.

New York City pharmaceutical giant Bristol Myers Squibb has selected the head of Sanofi Pasteur's biologics manufacturing to be the new general manager of its expanding facility in Devens.

Marlborough medical device company CardioFocus has announced the appointment of Stephan Ogilvie as its chief financial officer.